With approximately 5000 new cases in 2020, prostate cancer is the most common cancer in Finland.
We explore RNA and protein expression of prostate cancer, finding new game-changing biomarkers. By using artificial intelligence, we create algorithms for cancer recognition in pathological H&E slides and MRI images, connecting this to patient data.
We seek to translate our findings into clinical everyday practice and empower the future of precision medicine.
You can support our research by making a donation, making a will, or setting up an anniversary fundraising campaign and mentioning that you wish that your donation be directed to our group.
Every donation counts.
Contact:
lahjoittajasuhteet@helsinki.fi
029 41 21650